AIE增强的NIR-II发射超分子金属循环纳米平台用于瘤微环境响应化学光热免疫疗法
Yaofeng Chen1, Wei Ma1, Yanlu Yu1
1Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, Zhejiang, Hangzhou, 311121, P. R. China.
Advanced healthcare materials
|August 18, 2025
概括
这项研究引入了一种用于精密瘤学的新型纳米平台,结合了先进的成像,向药物输送和免疫治疗,以有效治疗乳腺癌并预防毒性最小的转移.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 多模纳米平台在精密瘤学方面具有前景,但面临着不稳定性和免疫活性低下等挑战.
- 开发具有可控释放和增强治疗效果的稳定纳米载体对于有效的癌症治疗至关重要.
研究的目的:
- 为了设计一个基于超分子金属循环的纳米平台 (M2S-AD NPs),用于先进的癌症治疗学.
- 整合聚合诱导排放 (AIE) 成像,瘤微环境 (TME) 响应性药物释放和免疫调节,以加强癌症治疗.
主要方法:
- 协调驱动的自组装和主机-客户封装被用于创建M2S-AD NP.
- 该纳米平台使用AIE用于NIR-II光成像,高光热转换效率用于切除,以及TME响应元素用于药物释放.
- 组合疗法包括光热切除,化疗和抗PD-L1免疫疗法.
主要成果:
- M2S-AD NPs展示了高效的NIR-II光成像和光热剥离,其转换效率为42.7%.
- 在富含谷氨的瘤中实现了选择性药物释放,在生理条件下稳定.
- 组合疗法在4T1乳腺瘤模型中消除了原发性瘤和抑制了转移 (>80%的瘤生长抑制) 而没有系统性毒性.
结论:
- 设计的M2S-ADNP代表了一种新型的超分子工程范式,用于下一代癌症治疗术.
- 这种方法有效地统一了成像,向药物输送和免疫调节,以对抗转移性乳腺癌.
- 该研究强调了将材料创新与免疫瘤学结合起来,用于治疗具有挑战性的恶性瘤的潜力.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


